AZO Stock Analysis: AutoZone | NYSE
Auto Parts | NYSE, USA | Market Cap: 49.500m USD | 12M Return: -19.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.18B
EPS Trend: 92.7%
Qual. Beats: 2
Rev. Trend: 99.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
AutoZone is a large-cap U.S. retailer and distributor of automotive replacement parts and accessories, operating stores in the United States, Mexico, and Brazil. The company sells new and remanufactured hard parts, maintenance items, and accessories for cars, SUVs, vans, and light-duty trucks, covering a broad catalog that includes batteries, brakes, filters, engine components, fluids, and tire repair products, alongside non-automotive merchandise such as tools, air fresheners, and snacks. In addition to serving do-it-yourself consumers, AutoZone runs a commercial sales program that provides credit and delivery to repair shops and fleet operators, and it sells diagnostic and shop-management software through the ALLDATA brand. E-commerce is handled through autozone.com and duralastparts.com, the latter promoting its private-label Duralast parts. The company was founded in 1979 and is headquartered in Memphis, Tennessee, and is classified within the Consumer Discretionary sector under Automotive Retail. The auto parts retail industry tends to be relatively defensive, as demand is supported by the large installed base of vehicles on the road and by a mix of DIY consumers and professional service accounts, with private-label brands commonly used to drive margins.
- Aging US vehicle fleet drives DIY replacement parts demand
- Commercial same-store sales accelerate as shop count expands
- Share repurchases and dividend hikes continue supporting EPS growth
| Net Income: 2.48b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -2.94 > 1.0 |
| NWC/Revenue: -5.51% < 20% (prev -7.83%; Δ 2.32% < -1%) |
| CFO/TA 0.15 > 3% & CFO 3.07b > Net Income 2.48b |
| Net Debt (15.9b) to EBITDA (4.26b): 3.72 < 3 |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.9m) vs 12m ago -2.06% < -2% |
| Gross Margin: 51.75% > 18% (prev 52.95%; Δ -1.19% > 0.5%) |
| Asset Turnover: 101.1% > 50% (prev 101.5%; Δ -0.40% > 0%) |
| Interest Coverage Ratio: 7.63 > 6 (EBIT TTM 3.60b / Interest Expense TTM 472.1m) |
| A: -0.05 (Total Current Assets 8.93b - Total Current Liabilities 10.0b) / Total Assets 20.9b |
| B: -0.18 (Retained Earnings -3.75b / Total Assets 20.9b) |
| C: 0.18 (EBIT TTM 3.60b / Avg Total Assets 19.8b) |
| D: -0.12 (Book Value of Equity -2.78b / Total Liabilities 23.7b) |
| Altman-Z'' = 0.17 = B |
| DSRI: 1.23 (Receivables 764.9m/588.5m, Revenue 20.0b/18.9b) |
| GMI: 1.02 (GM 52.95% / 51.75%) |
| AQI: 0.90 (AQ_t 0.04 / AQ_t-1 0.04) |
| SGI: 1.06 (Revenue 20.0b / 18.9b) |
| TATA: -0.03 (NI 2.48b - CFO 3.07b) / TA 20.9b) |
| Beneish M = -2.84 (Cap -4..+1) = A |
As of July 21, 2026, the stock is trading at USD 2994.13 with a total of 117,336 shares traded. Over the past week, the price has changed by -2.76%, over one month by +1.53%, over three months by -16.42% and over the past year by -19.72%.
Current recommended Stop Loss: 2852.00 (which is 4.7% or 1.4 ATR below the current price).
AutoZone has received a consensus analysts rating of 4.34. Therefore, it is recommended to buy AZO.
- StrongBuy: 17
- Buy: 6
- Hold: 5
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 3969.4 | 32.6% |
P/E Trailing = 21.187
P/E Forward = 17.5439
P/S = 2.4767
P/B = 13.383
P/EG = 1.3929
Revenue TTM = 20.0b USD
EBIT TTM = 3.60b USD
EBITDA TTM = 4.26b USD
Long Term Debt = 8.80b USD (from longTermDebt, last fiscal year)
Short Term Debt = 336.3m USD (from shortTermDebt, last quarter)
Debt = 16.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 3.50b
Net Debt = 15.9b USD (calculated: Debt 16.1b - CCE 253.7m)
Enterprise Value = 65.4b USD (49.5b + Debt 16.1b - CCE 253.7m)
Interest Coverage Ratio = 7.63 (Ebit TTM 3.60b / Interest Expense TTM 472.1m)
EV/FCF = 40.03x (Enterprise Value 65.4b / FCF TTM 1.63b)
FCF Yield = 2.50% (FCF TTM 1.63b / Enterprise Value 65.4b)
FCF Margin = 8.17% (FCF TTM 1.63b / Revenue TTM 20.0b)
Net Margin = 12.40% (Net Income TTM 2.48b / Revenue TTM 20.0b)
Gross Margin = 51.75% ((Revenue TTM 20.0b - Cost of Revenue TTM 9.64b) / Revenue TTM)
Gross Margin QoQ = 52.15% (prev 52.49%)
Tobins Q-Ratio = 3.13 (Enterprise Value 65.4b / Total Assets 20.9b)
Interest Expense / Debt = 2.93% (Interest Expense 472.1m / Debt 16.1b)
Taxrate = 20.84% (652.3m / 3.13b)
NOPAT = 2.85b (EBIT 3.60b * (1 - 20.84%))
Current Ratio = 0.89 (Total Current Assets 8.93b / Total Current Liabilities 10.0b)
Debt / Equity = -5.79 (negative equity) (Debt 16.1b / totalStockholderEquity, last quarter -2.78b)
Debt / EBITDA = 3.72 (Net Debt 15.9b / EBITDA 4.26b)
Debt / FCF = 9.72 (Net Debt 15.9b / FCF TTM 1.63b)
Total Stockholder Equity = -3.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.54% (Net Income 2.48b / Total Assets 20.9b)
RoE = -80.35% (negative equity) (Net Income TTM 2.48b / Total Stockholder Equity -3.08b)
RoCE = 63.03% (EBIT 3.60b / Capital Employed (Equity -3.08b + L.T.Debt 8.80b))
RoIC = 26.01% (NOPAT 2.85b / Invested Capital 11.0b)
WACC = 5.77% (E(49.5b)/V(65.6b) * Re(6.89%) + D(16.1b)/V(65.6b) * Rd(2.93%) * (1-Tc(0.21)))
Discount Rate = 6.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.48 | Cagr: -2.47%
[DCF] Terminal Value 73.10% ; FCFF base≈1.78b ; Y1≈1.56b ; Y5≈1.26b
[DCF] Fair Price = 267.8 (EV 20.3b - Net Debt 15.9b = Equity 4.37b / Shares 16.3m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 92.71 | EPS CAGR: 5.06% | SUE: 0.91 | # QB: 2
Revenue Correlation: 98.99 | Revenue CAGR: 4.74% | SUE: -0.69 | # QB: 0
EPS current Quarter (2026-11-30): EPS=38.14 | Chg30d=-0.42% | Revisions=+0% | Analysts=15
EPS current Year (2026-08-31): EPS=151.11 | Chg30d=+1.62% | Revisions=+79% | GrowthEPS=+4.3% | GrowthRev=+8.1%
EPS next Year (2027-08-31): EPS=175.49 | Chg30d=+0.20% | Revisions=+4% | GrowthEPS=+16.1% | GrowthRev=+7.4%
[Analyst] Revisions Ratio: +36% (up=36, down=16)